Neuropathology of white matter disease in Leber's hereditary optic neuropathy

Brain

Volumn 128, Issue 1, 2005, Pages 35-41

  Kovács, Gábor G ^a   Höftberger, Romana ^d   Majtényi, Katalin ^a   Horváth, Rita ^e   Barsi, Péter ^a   Komoly, Sámuel ^b   Lassmann, Hans ^d   Budka, Herbert ^d   Jakab, Gábor ^c  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^b Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

^c UZSOKI HOSPITAL   (Hungary)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Klinikum Schwabing   (Germany)

Author keywords

CD8 positive T cells; Demyelination; LHON; Mitochondrial disease; Multiple sclerosis

Indexed keywords

CD8 ANTIGEN; FORMALDEHYDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; NUCLEOTIDE; PARAFFIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; ARTICLE; BRAIN INJURY; BRONCHOPNEUMONIA; CASE REPORT; CELL DEATH; CELL VACUOLE; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; DETERIORATION; DISEASE DURATION; DISEASE EXACERBATION; ENZYME SUBUNIT; FEMALE; FRONTAL LOBE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; LEBER HEREDITARY OPTIC NEUROPATHY; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE INJURY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE DISEASE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; SEIZURE; SENILE PLAQUE; T LYMPHOCYTE; TISSUE INJURY; VISUAL IMPAIRMENT; VISUAL SYSTEM; WHITE MATTER;

ADULT; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OPTIC ATROPHY, HEREDITARY, LEBER; POINT MUTATION; SUPEROXIDE DISMUTASE;

EID: 11244291105     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh310     Document Type: Article

References (25)

1. Adams JH, Blackwood W, Wilson J. Further clinical and pathological observations on Leber's optic atrophy. Brain 1966; 89: 15-26.
2. Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta 1995; 1271: 111-21.
3. Beltran B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc Natl Acad Sci USA 2000; 97: 14602-7.
4. Carelli V, Sadun AA. Optic neuropathy in Lhon and Leigh syndrome. Ophthalmology 2001; 108: 1172-3.
5. Dobersen MJ, Hammer JA, Noronha AB, MacIntosh TD, Trapp BD, Brady RO, et al. Generation and characterization of mouse monoclonal antibodies to the myelin-associated glycoprotein (MAG). Neurochem Res 1985; 10: 499-513.
6. Funalot B, Reynier P, Vighetto A, Ranoux D, Bonnefont JP, Godinot C, et al. Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy. Ann Neurol 2002; 52: 374-7.
7. Harding AE, Sweeney MG, Miller DH, Mumford CF, Kellar-Wood H, Menard D, et al. Occurrence of a multiple sclerosis like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992; 115: 979-89.
8. Höftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 2004; 14: 43-50.
9. Horvath R, Abicht A, Shoubridge EA, Karcagi V, Rozsa C, Komoly S, et al. Leber's hereditary optic neuropathy presenting as multiple sclerosis-like disease of the CNS. J Neurol 2000; 247: 65-7.
10. Howell N. Human mitochondrial diseases: answering questions and questioning answers. Int Rev Cytol 1999; 186: 49-116.
11. Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 2001; 3: 119-25.
12. Kellar-Wood H, Robbertson N, Govan GG, Compston DA, Harding AE. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994; 36: 109-12.
13. Kwittken J, Barest HD. The neuropathology of hereditary optic atrophy (Leber' s disease); the first complete anatomic study. Am J Pathol 1958; 34: 185-207.
14. Lassmann H. Pathology of multiple sclerosis. In: Compston A, Ebers G, Lassmann H, editors. McAlpine's multiple sclerosis. 3rd edn. London: Churchill Livingstone; 1998. p. 323-58.
15. Lev D, Yanoov-Sharav M, Watemberg N, Leshinsky-Silver E, Lerman-Sagie T. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 2002; 6: 121-3.
16. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177: 95-103.
17. McFarland R, Taylor RW, Turnbull DM. The neurology of mitochondrial DNA disease. Lancet Neurol 2002; 1: 343-51.
18. Mojon D, Fujihara K, Hirano M, Miller C, Lincoff N, Jacobs D, et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in familial multiple sclerosis. Graefes Arch Clin Exp Ophthalmol 1999; 237: 348-50.
19. Muller W, Mennel HD, Bewermeyer K, Bewermeyer H. Is there a final common pathway in mitochondrial encephalomyopathies? Considerations based on an autopsy case of Kearns-Sayre syndrome. Clin Neuropathol 2003; 22: 240-5.
20. Oldfors A, Tulinius M. Mitochondrial encephalomyopathies. J Neuropathol Exp Neurol 2003; 62: 217-27.
21. Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 1993; 143: 555-64.
22. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-37.
23. Saadati HG, Hsu HY, Heller KB, Sadun AA. A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber hereditary optic neuropathy. Arch Ophthalmol 1998; 116: 911-6.
24. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nature Rev Immunol 2002; 2: 85-95.
25. Vanopdenbosch L, Dubois B, D'Hooghe MB, Meire F, Carton H. Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. J Neurol 2000; 247: 535-43.